This inventor holds 26 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Biomedical Devices. Top assignees: Accelerate Diagnostics, Inc., Intelligent Medicine, Inc., Accelr8 Technology Corporation. Active years: 1978-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Trumansburg, NY (US) (1978 - 1979)
- Minneapolis, MN (US) (1980 - 1982)
- Denver, CO (US) (1987 - 2023)
Company Filing History:
7 out of 21 
6 out of 7 
2 out of 8 Years Active: 1978-2023
Areas of Expertise:
Title: Unveiling the Innovations of David C Howson in Denver, CO
Introduction: David C Howson, a prolific inventor based in Denver, CO, has made significant contributions to the field of microbial growth and antimicrobial susceptibility through his groundbreaking inventions. With an impressive portfolio of 26 patents, Howson has revolutionized the way microorganism growth and antimicrobial agent susceptibility are determined.
Latest Patents: Howson's latest patents showcase his expertise in rapid determination of microbial growth and antimicrobial susceptibility. His inventions include systems and methods for swiftly determining microorganism growth and their susceptibility to antimicrobial agents. By utilizing techniques such as electrophoresis, centrifugation, and filtration, Howson has enabled sensitive and rapid assessment of microbial susceptibility to antimicrobials.
Career Highlights: Throughout his career, David C Howson has been associated with renowned companies such as Accelerate Diagnostics, Inc. and Intelligent Medicine, Inc. His innovative spirit and dedication to advancing the field of microbiology have led to the development of cutting-edge technologies that have the potential to transform healthcare practices worldwide.
Collaborations: In his quest for innovation, Howson has collaborated with esteemed professionals in the industry, including Steven W Metzger and David A Goldberg. Together, they have pushed the boundaries of microbial research, paving the way for new and improved methodologies in determining antimicrobial susceptibility.
Conclusion: David C Howson's trailblazing inventions in microbial growth and antimicrobial susceptibility stand as a testament to his ingenuity and dedication to scientific advancement. His impact on the field of microbiology is undeniable, and his contributions continue to inspire future generations of innovators in the quest for a healthier and safer world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile